The Oncosearch | Oncotarget

Bevacizumab in ovarian cancer: A critical review of phase III studies Review

Luigi Rossi, Monica Verrico, Eleonora Zaccarelli, Anselmo Papa, Maria Colonna, Martina Strudel, Patrizia Vici, Vincenzo Bianco, Federica Tomao

Published Nov 11, 2016 · Vol. 8, No. 7 · pp. 12389-12405

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients Clinical Research Papers

Doreen O. Jackson, Kevin Byrd, Timothy J. Vreeland, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Erika J. Schneble, John S. Berry, Alfred F. Trappey, Guy Travis Clifton, Mark O. Hardin, Jonathan Martin, John C. Elkas, Thomas P. Conrads, Kathleen M. Darcy, Chad A. Hamilton, George L. Maxwell, George E. Peoples

Published Nov 11, 2016 · Vol. 8, No. 9 · pp. 15912-15923

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group Research Paper

StÃ©phane Oudard, Reza Elaidi, Mara Brizard, CÃ©line Le Rest, ValÃ©rie Caillet, Sophie Deveaux, GÃ©rard Benoit, Jean-Michel CorrÃ©as, Farida Benoudiba, Philippe David, Alain Gaudric, Pascal Hammel, Dominique Joly, Marc Olivier Timsit, Arnaud MÃ©jean, StÃ©phane Richard

Published Nov 11, 2016 · Vol. 7, No. 51 · pp. 85306-85317

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma Research Paper

Seung Ah Choi, Pil Ae Kwak, Chul-Kee Park, Kyu-Chang Wang, Ji Hoon Phi, Ji Yeoun Lee, Chang Sik Lee, Ju-Hee Lee, Seung-Ki Kim

Published Nov 10, 2016 · Vol. 8, No. 6 · pp. 9123-9133

Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells Research Paper

Sheng-Feng Tsai, Michael Tao, Li-Ing Ho, Tzyy-Wen Chiou, Shinn-Zong Lin, Hong-Lin Su, Horng-Jyh Harn

Published Nov 10, 2016 · Vol. 8, No. 3 · pp. 4051-4061

Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells Research Paper

Feng Wei, Lijuan Ding, Zhentong Wei, Yandong Zhang, Yang Li, Luo Qinghua, Yuteng Ma, Liang Guo, Guoyue Lv, Yan Liu

Published Nov 10, 2016 · Vol. 7, No. 51 · pp. 85259-85272

Unveiling changes in the landscape of patient populations in cancer early drug development Review

Cinta Hierro, AnalÃa Azaro, Guillem ArgilÃ©s, Elena Elez, Patricia GÃ³mez, Joan Carles, Jordi Rodon

Published Nov 9, 2016 · Vol. 8, No. 8 · pp. 14158-14172

PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity Research Paper

Jian Wang, Hui Zhang, Xiaoqing Zhang, Peng Wang, Hongtao Wang, Fang Huang, Chenyan Zhou, Jianguang Zhou, Shanhu Li

Published Nov 9, 2016 · Vol. 7, No. 49 · pp. 81377-81388

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations Research Paper

Maria E. Riveiro, Lucile Astorgues-Xerri, Ramiro Vazquez, Roberta Frapolli, Ivo Kwee, Andrea Rinaldi, Elodie Odore, Keyvan Rezai, Mohamed Bekradda, Giorgio Inghirami, Maurizio Dâ€™Incalci, Kay Noel, Esteban Cvitkovic, Eric Raymond, Francesco Bertoni

Published Nov 7, 2016 · Vol. 7, No. 51 · pp. 84675-84687

Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 Research Paper

Beatrice Riva, Marco De Dominici, Ilaria Gnemmi, Samanta A. Mariani, Alberto Minassi, Valentina Minieri, Paolo Salomoni, Pier Luigi Canonico, Armando A. Genazzani, Bruno Calabretta, Fabrizio Condorelli

Published Nov 7, 2016 · Vol. 7, No. 49 · pp. 81555-81570

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor Research Paper

Xin Cheng, Yong-Qiang Liu, Gui-Zhen Wang, Li-Na Yang, Yong-Zhi Lu, Xin-Chun Li, Bo Zhou, Li-Wei Qu, Xiao-Lu Wang, Yong-Xian Cheng, Jinsong Liu, Sheng-Ce Tao, Guang-Biao Zhou

Published Nov 7, 2016 · Vol. 8, No. 2 · pp. 2681-2693

SUMOylated MAFB promotes colorectal cancer tumorigenesis Research Paper

Lin-Sen Yang, Xiao-Jian Zhang, Yin-Yin Xie, Xiao-Jian Sun, Ren Zhao, Qiu-Hua Huang

Published Nov 5, 2016 · Vol. 7, No. 50 · pp. 83488-83501

Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer Research Paper

Xiao-Lin Wang, Wei-Ping Shi, Hong-Can Shi1, Shi-Chun Lu, Kang Wang, Chao Sun, Jian-Sheng He, Wei-Guo Jin, Xiao-Xia Lv, Hui Zou, Yu-Sheng Shu

Published Nov 5, 2016 · Vol. 7, No. 49 · pp. 81527-81540

FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients Research Paper

Zheng Wang, Chuanbao Zhang, Lihua Sun, Jingshan Liang, Xing Liu, Guanzhang Li, Kun Yao, Wei Zhang, Tao Jiang

Published Nov 5, 2016 · Vol. 7, No. 51 · pp. 84587-84593

Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase Research Paper

Joanne Wayne, Teresa Brooks, Andrew J. Massey

Published Nov 4, 2016 · Vol. 7, No. 51 · pp. 85033-85048

Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics Research Paper

Hong Qu, Yuling Chen, Guangming Cao, Chongdong Liu, Jiatong Xu, Haiteng Deng, Zhenyu Zhang

Published Nov 4, 2016 · Vol. 7, No. 50 · pp. 83187-83199

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Clinical Research Papers

Hye Ryun Kim, Joung Soon Jang, Jong-Mu Sun, Myung-Ju Ahn, Dong-Wan Kim, Inkyung Jung, Ki Hyeong Lee, Joo-Hang Kim, Dae Ho Lee, Sang-We Kim, Byoung Chul Cho

Published Nov 3, 2016 · Vol. 8, No. 9 · pp. 15943-15951

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia Research Paper

Carolina Simioni, Simona Ultimo, Alberto M. Martelli, Giorgio Zauli, Daniela Milani, James A. McCubrey, Silvano Capitani, Luca M. Neri

Published Nov 3, 2016 · Vol. 7, No. 48 · pp. 79842-79853

HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation Research Paper

Luigi Alfano, Caterina Costa, Antonella Caporaso, Dario Antonini, Antonio Giordano, Francesca Pentimalli

Published Nov 1, 2016 · Vol. 7, No. 47 · pp. 78127-78139

Clinical outcomes based on multigene profiling in metastatic breast cancer patients Priority Research Paper

Reva K. Basho, Debora de Melo Gagliato, Naoto T. Ueno, Chetna Wathoo, Huiqin Chen, Maryam Shariati, Caimiao Wei, Ricardo H. Alvarez, Stacy L. Moulder, Aysegul A. Sahin, Sinchita Roy-Chowdhuri, Mariana Chavez-MacGregor, Jennifer K. Litton, Vincent Valero, Raja Luthra, Jia Zeng, Kenna R. Shaw, John Mendelsohn, Gordon B. Mills, Debu Tripathy, Funda Meric-Bernstam

Published Oct 28, 2016 · Vol. 7, No. 47 · pp. 76362-76373

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Bevacizumab in ovarian cancer: A critical review of phase III studies Review

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients Clinical Research Papers

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group Research Paper

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma Research Paper

Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells Research Paper

Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells Research Paper

Unveiling changes in the landscape of patient populations in cancer early drug development Review

PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity Research Paper

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations Research Paper

Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 Research Paper

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor Research Paper

SUMOylated MAFB promotes colorectal cancer tumorigenesis Research Paper

Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer Research Paper

FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients Research Paper

Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase Research Paper

Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics Research Paper

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Clinical Research Papers

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia Research Paper

HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation Research Paper

Clinical outcomes based on multigene profiling in metastatic breast cancer patients Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Bevacizumab in ovarian cancer: A critical review of phase III studies Review

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients Clinical Research Papers

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group Research Paper

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma Research Paper

Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells Research Paper

Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells Research Paper

Unveiling changes in the landscape of patient populations in cancer early drug development Review

PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity Research Paper

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations Research Paper

Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 Research Paper

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor Research Paper

SUMOylated MAFB promotes colorectal cancer tumorigenesis Research Paper

Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer Research Paper

FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients Research Paper

Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase Research Paper

Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics Research Paper

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Clinical Research Papers

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia Research Paper

HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation Research Paper

Clinical outcomes based on multigene profiling in metastatic breast cancer patients Priority Research Paper